Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is an ageing-related lung disorder characterised by expansion of the myofibroblast population and aberrant lung remodelling. Dehydroepiandrosterone (DHEA), a steroid pro-hormone, decreases with age but an exaggerated decline has been associated with chronic degenerative diseases. We quantified the plasma levels of DHEA and its sulfated form (DHEA-S) in 137 IPF patients and 58 controls and examined the effects of DHEA on human lung fibroblasts. Plasma DHEA/DHEA-S was significantly decreased in male IPF patients (median (range) DHEA: 4.4 (0.2–29.2) versus 6.7 (2.1–15.2) ng·mL−1, p<0.01; DHEA-S: 47 (15.0–211) versus 85.2 (37.6–247.0) μg·dL−1, p<0.001), while in females only DHEA-S was significantly decreased (32.6 (15.0–303.0) versus 68.3 (16.4–171) μg·dL−1, p<0.001). DHEA caused a decrease in fibroblast proliferation and an approximately two-fold increase in fibroblast apoptosis, probably through the intrinsic pathway with activation of caspase-9. This effect was accompanied by upregulation of several pro-apoptotic proteins (Bax and cyclin-dependent kinase-inhibitor CDNK1A) and downregulation of anti-apoptotic proteins, such as cellular inhibitor of apoptosis (c-IAP)1 and c-IAP2. DHEA also caused a significant decrease of transforming growth factor-&bgr;1-induced collagen production and fibroblast to myofibroblast differentiation, and inhibited platelet-derived growth factor-induced fibroblast migration. These findings demonstrate a disproportionate decrease of DHEA/DHEA-S in IPF patients and indicate that this molecule has multiple antifibrotic properties. DHEA/DHEA-S is abnormally decreased in IPF patients and this adrenal steroid has strong antifibrotic effects in vitro http://ow.ly/nD9sz

[1]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  D. Steinhilber,et al.  Selective Non-Steroidal Glucocorticoid Receptor Agonists Attenuate Inflammation but Do Not Impair Intestinal Epithelial Cell Restitution In Vitro , 2012, PloS one.

[3]  Moisés Selman,et al.  Idiopathic pulmonary fibrosis , 2011, The Lancet.

[4]  S. Bonnet,et al.  Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. , 2011, American journal of physiology. Heart and circulatory physiology.

[5]  R. López-Marure,et al.  Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. , 2011, European journal of pharmacology.

[6]  J. Meléndez-Zajgla,et al.  Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis , 2011, European Respiratory Journal.

[7]  J. Holloszy,et al.  Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans , 2011, Aging.

[8]  Theodora Calogeropoulou,et al.  Neurosteroid Dehydroepiandrosterone Interacts with Nerve Growth Factor (NGF) Receptors, Preventing Neuronal Apoptosis , 2011, PLoS biology.

[9]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[10]  D. Carroll,et al.  University of Birmingham Cortisol, dehydroepiandrosterone sulphate, their ratio and hypertension: evidence of associations in male veterans from the Vietnam Experience Study. , 2012 .

[11]  H. Ahsan,et al.  Role of Bcl-2 family proteins and caspases in the regulation of apoptosis , 2011, Molecular and Cellular Biochemistry.

[12]  M. Selman,et al.  Aging and interstitial lung diseases: unraveling an old forgotten player in the pathogenesis of lung fibrosis. , 2010, Seminars in respiratory and critical care medicine.

[13]  J. Schröder,et al.  Skin and brain age together: The role of hormones in the ageing process , 2010, Experimental Gerontology.

[14]  E. Barrett-Connor,et al.  Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  T. Okanoue,et al.  Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non‐alcoholic steatohepatitis in Japanese patients , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

[16]  I. Lavrik.  Systems biology of apoptosis signaling networks. , 2010, Current opinion in biotechnology.

[17]  R. Ray,et al.  Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. , 2010, Cancer research.

[18]  E. White,et al.  Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  J. Dyck,et al.  Dehydroepiandrosterone Reverses Systemic Vascular Remodeling Through the Inhibition of the Akt/GSK3-β/NFAT Axis , 2009, Circulation.

[20]  M. Armanios.  Syndromes of telomere shortening. , 2009, Annual review of genomics and human genetics.

[21]  M. Kampa,et al.  Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites. , 2009, Experimental cell research.

[22]  C. Ohlsson,et al.  Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. , 2009, The Journal of clinical endocrinology and metabolism.

[23]  T. Yaguchi,et al.  Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A2a adenosine receptors , 2009, Journal of Gastroenterology.

[24]  P. Lansdorp,et al.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.

[25]  L. Walker,et al.  Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[26]  T. Buford,et al.  Impact of DHEA(S) and cortisol on immune function in aging: a brief review. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[27]  S. Sanderson,et al.  Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease , 2007, Hepatology.

[28]  H. Ho,et al.  Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function. , 2008, International journal of oncology.

[29]  A. Estrada,et al.  Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. , 2008, American journal of respiratory and critical care medicine.

[30]  L. Huang,et al.  Hypoxic Suppression of the Cell Cycle Gene CDC25A in Tumor Cells , 2007, Cell cycle.

[31]  J. Norris,et al.  Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. , 2007, American journal of respiratory and critical care medicine.

[32]  David S. Rogers,et al.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. , 2007, Cellular signalling.

[33]  T. Yoshikawa,et al.  Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes. , 2007, Current diabetes reviews.

[34]  A. Genazzani,et al.  Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly? , 2007, Drugs & aging.

[35]  Yigong Shi,et al.  Apoptosome: a platform for the activation of initiator caspases , 2007, Cell Death and Differentiation.

[36]  G. Oster,et al.  Incidence and prevalence of idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[37]  M. Selman,et al.  Acidic fibroblast growth factor decreases alpha-smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[38]  L. Montaño,et al.  DHEA‐Induced Antiproliferative Effect in MCF‐7 Cells Is Androgen‐ and Estrogen Receptor‐Independent , 2006, Cancer journal.

[39]  R. Prough,et al.  The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors , 2006, Drug metabolism reviews.

[40]  Naftali Kaminski,et al.  Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.

[41]  S. Ito,et al.  Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. , 2005, American journal of physiology. Endocrinology and metabolism.

[42]  Yanfang Jiang,et al.  Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone , 2005, Journal of Gastroenterology.

[43]  T. Yanase,et al.  Dehydroepiandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase. , 2005, Biochimica et biophysica acta.

[44]  Dongmin Liu,et al.  Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor , 2004, Steroids.

[45]  V. Keshamouni,et al.  Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor* , 2004, Journal of Biological Chemistry.

[46]  B. C. Kim,et al.  Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture. , 2000, Journal of dermatological science.

[47]  J. Morley,et al.  Endocrinology in aging. , 1988, Disease-a-month : DM.